Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

Related Articles by Review for PubMed (Select 21819165)

1.

Improving outcomes in patients at risk for venous thromboembolism following total knee and total hip replacement: implications for managed care.

Navarro RP, Barr JE, Faubus K, Sabharwal AD, Stern E, Unger K.

Am J Manag Care. 2011 Jul;17 Suppl 9:S251-8. Review.

PMID:
21819165
2.
3.
4.

[Prophylaxis of venous thromboembolism in orthopedic surgery].

Giuseppini MU, Guiducci S, Bardelli M.

Minerva Med. 2010 Feb;101(1):49-58. Review. Italian.

PMID:
20228720
5.

Cost-effectiveness of rivaroxaban versus enoxaparin for the prevention of postsurgical venous thromboembolism in Canada.

Diamantopoulos A, Lees M, Wells PS, Forster F, Ananthapavan J, McDonald H.

Thromb Haemost. 2010 Oct;104(4):760-70. doi: 10.1160/TH10-01-0071. Epub 2010 Aug 30. Review.

PMID:
20806107
6.

Thromboprophylaxis in major knee and hip replacement surgery: a review.

Eymin G, Jaffer AK.

J Thromb Thrombolysis. 2012 Nov;34(4):518-25. doi: 10.1007/s11239-012-0751-5. Review.

PMID:
22653706
7.

Rivaroxaban: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery.

Duggan ST, Scott LJ, Plosker GL.

Drugs. 2009;69(13):1829-51. doi: 10.2165/11200890-000000000-00000. Review.

PMID:
19719335
9.

Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review.

Kapoor A, Chuang W, Radhakrishnan N, Smith KJ, Berlowitz D, Segal JB, Katz JN, Losina E.

Pharmacoeconomics. 2010;28(7):521-38. doi: 10.2165/11535210-000000000-00000. Review.

10.

Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty.

Kwong LM.

Am J Manag Care. 2011 Feb;17(1 Suppl):S22-6. Review.

11.

Optimizing the prevention of venous thromboembolism: recent quality initiatives and strategies to drive improvement.

Amin AN, Deitelzweig SB.

Jt Comm J Qual Patient Saf. 2009 Nov;35(11):558-64. Review.

PMID:
19947332
12.

Cost-effectiveness of venous thromboembolism prophylaxis in total hip and knee replacement surgery: the evolving application of health economic modelling over 20 years.

Wolowacz SE, Hess N, Brennan VK, Monz BU, Plumb JM.

Curr Med Res Opin. 2008 Oct;24(10):2993-3006. doi: 10.1185/03007990802443255 . Epub 2008 Sep 23. Review.

PMID:
18814825
13.

A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty.

Dahl OE, Quinlan DJ, Bergqvist D, Eikelboom JW.

J Thromb Haemost. 2010 Sep;8(9):1966-75. doi: 10.1111/j.1538-7836.2010.03965.x. Review.

PMID:
20586919
14.

Pharmacoeconomic implications of thromboprophylaxis with new oral anticoagulants after total hip or knee replacement in the USA.

Nutescu EA.

Expert Opin Pharmacother. 2013 Mar;14(4):525-34. doi: 10.1517/14656566.2013.774374. Review.

PMID:
23438423
15.
16.

Prevention of VTE Following total hip and knee arthroplasty in Hemophilia patients.

Stein MI, Park J, Raterman S.

Orthopedics. 2011 May;34(5):393. doi: 10.3928/01477447-20110317-21. Review.

PMID:
21553745
17.
18.

Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.

Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Langhorne P, Brenkel I, Regan L, Greer I.

Health Technol Assess. 2006 Apr;10(11):1-110. Review.

19.

The ''critical thrombosis period'' in major orthopedic surgery: when to start and when to stop prophylaxis.

Warwick D, Rosencher N.

Clin Appl Thromb Hemost. 2010 Aug;16(4):394-405. doi: 10.1177/1076029609355151. Epub 2009 Dec 16. Review.

PMID:
20019020
20.

The importance of appropriate prophylaxis for the prevention of venous thromboembolism in at-risk medical patients.

Dobesh P.

Int J Clin Pract. 2010 Oct;64(11):1554-62. doi: 10.1111/j.1742-1241.2010.02447.x. Review.

PMID:
20846203
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk